Loading clinical trials...

Mogamulizumab Q4week Dosing in Participants With R/R CTCL | Clinical Trials | Clareo Health

Active Not RecruitingPhase 2NCT04745234

Mogamulizumab Q4week Dosing in Participants With R/R CTCL

This is an open-label, multicenter, Phase 2 study to evaluate the safety and tolerability of mogamulizumab given Q4W following initial weekly induction in adult participants with relapsed/refractory M...

Lead sponsor: Kyowa Kirin, Inc.•7 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

UNKNOWNPhase 1

Study of CD4-Targeted Chimeric Antigen Receptor T-Cells (CD4- CAR-T) in Subjects With Relapsed or Refractory T-Cell Lymphoma

NCT04712864 · T-Cell Lymphoma, Peripheral T-Cell Lymphoma Refractory, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 25, 2024Terms

Trial snapshot

StatusACTIVE_NOT_RECRUITING

PhasePHASE2

Enrollment34

Start dateAug 2021

Last updatedApr 25, 2024

Condition

Cutaneous T-Cell Lymphoma, Relapsed Cutaneous T-Cell Lymphoma Refractory

Locations shown

City of Hope National Medical Center

Duarte, California

University of California Irvine

Irvine, California

Stanford Cancer Center

Stanford, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 25, 2024Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions